Supplementary Figure S1 from Early Detection of Malignant and Premalignant Peripheral Nerve Tumors Using Cell-Free DNA Fragmentomics

R. Taylor Sundby; Jeffrey J. Szymanski; Alexander Pan; Paul A. Jones; Sana Mahmood; Olivia H. Reid; Divya Srihari; Amy E. Armstrong; Stacey Chamberlain; Sanita Burgic; Kara Weekley; Béga Murray; S. G. Patel; Faridi Qaium; Andrea N. Lucas; Margaret Fagan; Anne Dufek; Christian F. Meyer; Natalie B. Collins; Christine A. Pratilas; Eva Dombi; Andrea M. Gross; AeRang Kim; John S.A. Chrisinger; Carina Dehner; Brigitte C. Widemann; Angela C. Hirbe; Aadel A. Chaudhuri; Jack F. Shern

doi:10.1158/1078-0432.27142189

Abstract

Supplemental Figure 1. Attributes of atypical neurofibroma samples. Histologic characteristics and, when available, TSO500 clinical sequencing results for paired tissue corresponding with AN cell-free DNA.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Sundby et al. (2024) studied this question.

synapsesocial.com/papers/68e56226e2b3180350efef0c https://doi.org/10.1158/1078-0432.27142189

View at Publisher

Ask AI

Bookmark

Share

Supplementary Figure S1 from Early Detection of Malignant and Premalignant Peripheral Nerve Tumors Using Cell-Free DNA Fragmentomics

Abstract

Discussion

Cite This Study

Supplementary Figure S1 from Early Detection of Malignant and Premalignant Peripheral Nerve Tumors Using Cell-Free DNA Fragmentomics

Abstract

Discussion

Cite This Study

Keep reading

Keep reading